Essity B 293.5 (-2.1 SEK) on 21-Dec-2024 17:29

Brands


image1

Essity’s Capital Markets Day 2024 was held at the company's production facility for hygiene products in Valls, Spain. The company’s strategy for accelerating profitable growth and the roadmap to achieving the company’s financial targets was presented. The day also included a guided tour of the production facility and a demonstration of the global transport and logistics center and innovations within the company's various categories.

Download the presentations from the day here (pdf) and watch videopresentations below. 

Agenda for the day:

Agenda CMD (1)

If you want to know more about Essity as an investment, please reach out to Investor Relations via the contact details below.

Video of the full event

Essity’s Capital Markets Day 2024

Accelerating Profitable Growth
  • Magnus Groth, President and CEO
  • Sahil Tesfu, Chief Strategy Officer
  • Fredrik Rystedt, CFO and EVP
Global Supply Chain – Driving margin expansion
  • Donato Giorgio, President Global Supply Chain
  • Miriam Guash, Operations Director Spain
  • Ilham Smaali, VP Planning & Logistics
Health & Medical – Grow to scale
  • Ulrika Kolsrud, President Health & Medical
  • Ida Emus, VP Sales & Marketing Region UK, Ireland & South
  • Anand Chandarana, VP Global Marketing & Innovation, Medical
Global Brand, Innovation & Sustainability – Fuelling profitable growth
  • Tuomas Yrjölä, President Global Brand, Innovation & Sustainability
  • Meta Redstedt, Global Master Brand & Communication Director
Consumer Goods – Accelerate high-margin categories
  • Volker Zöller, President Consumer Goods EMEA
  • Andres Gomez, President Consumer Goods Americas
Professional Hygiene – Expand global leadership
  • Pablo Fuentes, President Professional Hygiene
  • Matthew Urmanski, VP Sales & Marketing North America

Investor Relations Contacts

Sandra Åberg
Vice President Investor Relations

Direct: +46 70 564 96 89
Viveca Dominguez
Investor Relations Director

Direct: +46 70 278 51 52
Janet Östergren
Investor Relations Specialist

Direct: +46 70 310 13 74
General investors contact